As part of a global trial called KARDIA-2, researchers injected people with hard-to-treat high blood pressure with a medication called zilebesiran. This is designed to be administered every six months ...

Drs Marwah Abdalla and Sandra J. Taler discuss practical workups in a busy practice when secondary hypertension is suspected, ...

Patients with untreated or uncontrolled hypertension who started antihypertensive monotherapy in the first month after diagnosis were more likely to achieve blood pressure (BP) control at 6 months ...

Please provide your email address to receive an email when new articles are posted on . Lifetime risk for hypertension is up to 90% among U.S. adults. Updated guidelines and a pipeline of novel drugs ...